Ignite Creation Date:
2025-12-24 @ 2:31 PM
Ignite Modification Date:
2026-01-04 @ 8:42 AM
Study NCT ID:
NCT00001959
Status:
COMPLETED
Last Update Posted:
2014-05-26
First Post:
2000-01-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)
Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
000042
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None